29.05.2024 14:31:57
|
Assertio Names O'Grady CEO
(RTTNews) - Assertio Holdings, Inc. (ASRT) announced the appointment of Brendan O'Grady as chief executive officer and board member, effective May 29, 2024.
O'Grady, is a seasoned healthcare executive with over 30 years of experience, and previously served as CEO of the Global Formulations business at Glenmark Pharmaceuticals.
The company also said that Heather Mason, the Interim CEO, will return to her position as an independent director.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Depomed Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |